![The Trade Desk logo](/static/img/stocks/ttd.png) |
The Trade Desk
TTD
|
$ 80.33
|
$ 39.3 B
|
$ 84 M
|
259.1
|
29.8
|
$ 0.5
|
![usa](/static/img/countries/usa.png) |
![MongoDB logo](/static/img/stocks/mdb.png) |
MongoDB
MDB
|
$ 289.28
|
$ 20.6 B
|
$ -235 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Acceleron Pharma Inc. logo](/static/img/stocks/xlrn.png) |
Acceleron Pharma Inc.
XLRN
|
$ 179.68
|
$ 10.9 B
|
$ -60.9 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Enphase Energy logo](/static/img/stocks/enph.png) |
Enphase Energy
ENPH
|
$ 63.5
|
$ 8.66 B
|
$ 179 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Freshpet logo](/static/img/stocks/frpt.png) |
Freshpet
FRPT
|
$ 130.07
|
$ 6.26 B
|
$ 79.9 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Axsome Therapeutics logo](/static/img/stocks/axsm.png) |
Axsome Therapeutics
AXSM
|
$ 130.6
|
$ 5.93 B
|
$ -265 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Krystal Biotech logo](/static/img/stocks/krys.png) |
Krystal Biotech
KRYS
|
$ 152.72
|
$ 4.15 B
|
$ 4.05 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Rhythm Pharmaceuticals logo](/static/img/stocks/rytm.png) |
Rhythm Pharmaceuticals
RYTM
|
$ 56.96
|
$ 3.29 B
|
$ -189 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Veracyte logo](/static/img/stocks/vcyt.png) |
Veracyte
VCYT
|
$ 41.06
|
$ 2.98 B
|
$ -1.28 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Amicus Therapeutics logo](/static/img/stocks/fold.png) |
Amicus Therapeutics
FOLD
|
$ 9.73
|
$ 2.87 B
|
$ 9.53 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Five9 logo](/static/img/stocks/fivn.png) |
Five9
FIVN
|
$ 40.03
|
$ 2.83 B
|
$ -39.5 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![LeMaitre Vascular logo](/static/img/stocks/lmat.png) |
LeMaitre Vascular
LMAT
|
$ 98.53
|
$ 2.19 B
|
$ 52.1 M
|
60.1
|
11.1
|
$ 1.7
|
![usa](/static/img/countries/usa.png) |
![Tandem Diabetes Care logo](/static/img/stocks/tndm.png) |
Tandem Diabetes Care
TNDM
|
$ 33.4
|
$ 2.18 B
|
$ -211 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![AtriCure logo](/static/img/stocks/atrc.png) |
AtriCure
ATRC
|
$ 40.63
|
$ 1.88 B
|
$ -25.5 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Allegiance Bancshares logo](/static/img/stocks/abtx.png) |
Allegiance Bancshares
ABTX
|
$ 41.63
|
$ 1.51 B
|
$ 5.29 M
|
11.0
|
∙ |
$ 3.8
|
![usa](/static/img/countries/usa.png) |
![ACM Research logo](/static/img/stocks/acmr.png) |
ACM Research
ACMR
|
$ 23.84
|
$ 1.43 B
|
$ 149 M
|
13.1
|
1.7
|
$ 1.6
|
![usa](/static/img/countries/usa.png) |
![Everbridge logo](/static/img/stocks/evbg.png) |
Everbridge
EVBG
|
$ 35.0
|
$ 1.42 B
|
$ -26.2 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![CareDx, Inc logo](/static/img/stocks/cdna.png) |
CareDx, Inc
CDNA
|
$ 24.31
|
$ 1.31 B
|
$ -54.1 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Phibro Animal Health Corporation logo](/static/img/stocks/pahc.png) |
Phibro Animal Health Corporation
PAHC
|
$ 25.74
|
$ 1.04 B
|
$ 118 M
|
45.4
|
0.8
|
$ 0.5
|
![usa](/static/img/countries/usa.png) |
![Intellia Therapeutics logo](/static/img/stocks/ntla.png) |
Intellia Therapeutics
NTLA
|
$ 10.74
|
$ 953 M
|
$ -420 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![STAAR Surgical Company logo](/static/img/stocks/staa.png) |
STAAR Surgical Company
STAA
|
$ 15.35
|
$ 745 M
|
$ 38.7 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Castle Biosciences logo](/static/img/stocks/cstl.png) |
Castle Biosciences
CSTL
|
$ 27.49
|
$ 737 M
|
$ 1.59 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Zogenix, Inc. logo](/static/img/stocks/zgnx.png) |
Zogenix, Inc.
ZGNX
|
$ 11.85
|
$ 664 M
|
$ 23.7 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Arcturus Therapeutics Holdings logo](/static/img/stocks/arct.png) |
Arcturus Therapeutics Holdings
ARCT
|
$ 18.1
|
$ 482 M
|
$ -78.1 M
|
∙ |
∙ |
∙ |
![israel](/static/img/countries/israel.png) |
![TechTarget logo](/static/img/stocks/ttgt.png) |
TechTarget
TTGT
|
$ 15.77
|
$ 447 M
|
$ 60.9 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Cara Therapeutics logo](/static/img/stocks/cara.png) |
Cara Therapeutics
CARA
|
$ 5.2
|
$ 282 M
|
$ -85.2 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Kodiak Sciences logo](/static/img/stocks/kod.png) |
Kodiak Sciences
KOD
|
$ 5.22
|
$ 274 M
|
$ -280 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![MicroVision logo](/static/img/stocks/mvis.png) |
MicroVision
MVIS
|
$ 1.34
|
$ 245 M
|
$ -80 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Compugen Ltd. logo](/static/img/stocks/cgen.png) |
Compugen Ltd.
CGEN
|
$ 2.21
|
$ 194 M
|
∙ |
∙ |
8.9
|
∙ |
![israel](/static/img/countries/israel.png) |
![Fate Therapeutics logo](/static/img/stocks/fate.png) |
Fate Therapeutics
FATE
|
$ 1.45
|
$ 143 M
|
$ -257 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Cardlytics logo](/static/img/stocks/cdlx.png) |
Cardlytics
CDLX
|
$ 3.53
|
$ 129 M
|
$ -182 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Applied Therapeutics logo](/static/img/stocks/aplt.png) |
Applied Therapeutics
APLT
|
$ 0.65
|
$ 54.8 M
|
$ -82.9 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![Iovance Biotherapeutics logo](/static/img/stocks/iova.png) |
Iovance Biotherapeutics
IOVA
|
$ 5.54
|
$ 1.3 M
|
$ -415 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |
![EverQuote logo](/static/img/stocks/ever.png) |
EverQuote
EVER
|
$ 21.81
|
$ 727 K
|
$ -14.4 M
|
∙ |
∙ |
∙ |
![usa](/static/img/countries/usa.png) |